Cargando…
Synthesis and Biological Evaluation of Arylamide Sulphonate Derivatives as Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 and -3 Inhibitors
[Image: see text] Aberrant level of ectonucleotide pyrophosphatase/phosphodiesterase-1 and -3 is linked with numerous disorders, for instance, diabetes, cancer, osteoarthritis, chondrocalcinosis, and allergic reactions. These disorders may be cured or minimized by blocking the activity of ENPP1 and...
Autores principales: | Ullah, Saif, Pelletier, Julie, Sévigny, Jean, Iqbal, Jamshed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352230/ https://www.ncbi.nlm.nih.gov/pubmed/35936461 http://dx.doi.org/10.1021/acsomega.2c03473 |
Ejemplares similares
-
Role of ectonucleotide pyrophosphatase/phosphodiesterase 2 in the midline axis formation of zebrafish
por: Frisca, Frisca, et al.
Publicado: (2016) -
Crystal structure and substrate binding mode of ectonucleotide phosphodiesterase/pyrophosphatase-3 (NPP3)
por: Döhler, Christoph, et al.
Publicado: (2018) -
Hip Geometry Variation in Homozygous Ectonucleotide Pyrophosphatase/ Phosphodiesterase 1 (ENPP1) Deficient Patients
por: Theng, Elizabeth H, et al.
Publicado: (2021) -
The hepatic ectonucleotide pyrophosphatase/phosphodiesterase 1 gene mRNA abundance is reduced by insulin and induced by dexamethasone
por: Ma, Huiwen, et al.
Publicado: (2018) -
K121Q polymorphism in the Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 gene is associated with acute kidney rejection
por: Sortica, Denise A., et al.
Publicado: (2019)